CluePoints, has announced the success of its complimentary COVID-19 risk management package alongside comprehensive support for COVID-19 affected trials. Launched in April in the wake…
Understanding and monitoring meditation adherence during clinical trials is a problematic process. Researchers need to know that trial participants have administered the correct dosage at…
Sorrel Medical, a developer and manufacturer of wearable drug delivery devices, has announced the opening of a new manufacturing facility with state-of-the-art cleanroom facilities to…
Precision diagnostics company BillionToOne today announced a significant development in the struggle against the COVID-19 pandemic. BillionToOne has developed a highly accurate and cost-effective novel COVID-19…
ERT have announced a cardiac safety solution that helps biopharmaceutical researchers continue important clinical trials during current global Coronavirus ‘stay home’ mandates. The solution enables…
A partnership between Aptar Pharma and Lupin Limited has led to the launch of India’s first connected device for metered-dose inhalers (MDI) called ADHERO. This…
PatchAi has announced that it has closed two rounds of fundraising for about 900 thousand euros during 2019, which will help increase the availability of…
Signant Health has released the findings from its latest “State of eConsent” report which highlight the sentiments, successes, and challenges of eConsent practitioners around the…
As we go into 2020, nearly 70 percent of all healthcare providers are digital natives. Their personal experiences with mobile, social, and digital technologies are…
Dr Todd Everhart is Signant Health’s Clinical Vice President, newly appointed to accelerate intelligent eCOA and Predictive Data Analytics in Medical Clinical Research. He speaks…
